Restylane Refyne and Restylane Defyne are the first Optimal Balance Technology (OBT) hyaluronic acid injectables ever approved and launched in Japan, bringing advanced flexibility and natural movement ...

Results showed that 74% of Restylane Defyne-treated patients achieved significantly improved chin projection for up to 1 year. The Food and Drug Administration (FDA) has approved Restylane ® Defyne ...

Galderma, the brand behind fillers like Restylane, Dysport and Sculptra Aesthetic, announced today the FDA approval of two new fillers to the Restylane category: Restylane Refyne and Restylane Defyne.

This expands Galderma’s Restylane portfolio in Japan to four products, enabling treatment of a wider spectrum of patient and practitioner needs 3,4 These two new launches underscore Galderma’s ...

Galderma (SIX: GALD), the pure-play dermatology category leader, has announced the launch of Restylane Defyne and Restylane Refyne: the first OBT‑based hyaluronic acid injectables ever authorized in ...

There's a new filler in town (actually, two new fillers) and they're billed as the next big thing in the fight against laugh lines. Galderma, the pharmaceutical company behind injectables like ...

Hyaluronic acid 20mg/mL, lidocaine 3mg/mL; injectable gel implant. Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to ...

Restylane is a line of hyaluronic acid–based facial fillers that help smooth wrinkles and plump your cheeks and lips. Hyaluronic acid occurs naturally in our skin, especially in connective tissue.

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Restylane Defyne for mild to moderate chin retrusion augmentation in adults older than 21 ...